Adtalem Global Education to Announce Fiscal Second Quarter 2024 Results After Market Close Today
- None.
- None.
The company’s earnings announcement was originally scheduled for Thursday, February 1, 2024. In light of market news today, Adtalem has rescheduled its earnings announcement to provide a timely update on the company’s performance and guidance.
Adtalem will host a conference call at 4:00 p.m. CT (5:00 p.m. ET) today to discuss the results. The call can be accessed by dialing +1 877-407-6184 (
Adtalem will archive a replay of the call for 30 days. To access the replay, dial +1 877-660-6853 (
About Adtalem Global Education
Adtalem Global Education (NYSE: ATGE) is a national leader in post-secondary education and leading provider of professional talent to the healthcare industry. With a dedicated focus on driving strong outcomes that increase workforce preparedness, Adtalem empowers a diverse learner population to achieve their goals and make inspiring contributions to their communities. Adtalem is the parent organization of American University of the Caribbean School of Medicine, Chamberlain University, Ross University School of Medicine, Ross University School of Veterinary Medicine and Walden University. Adtalem’s family of institutions has more than 300,000 alumni and nearly 10,000 employees. Adtalem was named one of America’s Most Responsible Companies in 2021 and 2023 by Newsweek and Statista, and one of America’s Best Employers for Diversity in 2021 and 2022 by Forbes and Statista. Visit Adtalem.com for more information and follow us on LinkedIn, Instagram and Facebook.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240130188889/en/
Investor Contact
Jay Spitzer
Investor.Relations@Adtalem.com
+1 312-906-6600
Media Contact
Talisha Holmes
AdtalemMedia@Adtalem.com
+1 872-270-0331
Source: Adtalem Global Education
FAQ
When will Adtalem Global Education Inc. release its fiscal 2024 second quarter results?
Why did Adtalem reschedule its earnings announcement?
How can I access the conference call to discuss Adtalem's results?